drugs Class II Updated 2014-08-20

Teva Pharmaceuticals USA recalls Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count b

Recalled Product

Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA, NDC 0093-0293-10


Hazard / Issue

Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: lot 29C220, Exp. 11/15
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →